China healthcare : a growing force

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>Leverenz, Justin</dc:creator>
<dc:creator>Invesco</dc:creator>
<dc:date>2021-05-28</dc:date>
<dc:description xml:lang="es">Sumario: Over the past few years, the Chinese health care system has undergone significant reform. Initiatives to stimulate innovation, especially around drug research and development (R&D), have been the most impactful, in our view. The result is a booming drug R&D ecosystem including quality biotechs and their R&D outsourcing partner companies</dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/176370.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>Invesco</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Salud</dc:subject>
<dc:subject xml:lang="es">Biotecnología</dc:subject>
<dc:subject xml:lang="es">Innovación</dc:subject>
<dc:subject xml:lang="es">China</dc:subject>
<dc:type xml:lang="es">Books</dc:type>
<dc:title xml:lang="es">China healthcare : a growing force</dc:title>
<dc:relation xml:lang="es">En: Invesco. - 28 May 2021</dc:relation>
<dc:coverage xml:lang="es">China</dc:coverage>
</rdf:Description>
</rdf:RDF>